Home > Platform Technologies > Analgesics > Program Reports

Cytogel has completed pre-clinical toxicology and safety studies and filed as IND application required for the advancement of Cyt-1010 into human clinical trials. A first in-man Phase I study has been conducted and has provided an early demonstration of pharmacodynamic activity in addition to the primary objectives of demonstrating safety and assessing pharmacokinetics.